+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The interaction between medical burden and anticholinergic cognitive burden on neuropsychological function in a geriatric primary care sample

The interaction between medical burden and anticholinergic cognitive burden on neuropsychological function in a geriatric primary care sample

Archives of Clinical Neuropsychology 30(2): 105-113

Poorer neuropsychological function is associated with increased medical burden (MB) and the use of more anticholinergic medications. However, the interaction between MB and anticholinergic cognitive burden (AB) on neuropsychological performance is unknown. In a sample of 290 elderly primary care patients, those with a greater level of AB demonstrated poorer Total Index performance on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Further, an interaction effect was noted such that there was a greater anticholinergic effect on RBANS Total, Attention, and Delayed Memory Index scores for participants with fewer MB. Participants with more MB demonstrated poorer performance irrespective of their level of AB. These results indicate that MB effects may be overshadowed by anticholinergic effects in older patients.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 059081756

Download citation: RISBibTeXText

PMID: 25549761

DOI: 10.1093/arclin/acu073

Related references

Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs and Aging 30(2): 103-112, 2013

Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale. Drugs & Aging 30(2): 103-112, 2013

Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients. Plos One 12(2): E0171353, 2017

Role of anticholinergic burden in primary care patients with first cognitive complaints. European Journal of Neurology 24(7): 950-955, 2017

Cognitive, functional and behavioral factors associated with the burden of caring for geriatric patients with cognitive impairment or depression: evidence from a South American sample. International Journal of Geriatric Psychiatry 24(4): 382-389, 2008

Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study. Journal of Clinical Pharmacy and Therapeutics 43(5): 682-694, 2018

Reducing the burden of morbidity and medical utilization of older patients by outpatient geriatric services: implications to primary health-care settings. Geriatrics and Gerontology International 12(4): 612-621, 2013

Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population. PharmacoTherapy 36(11): 1123-1131, 2016

The contribution of cognitive impairment, medical burden, and psychopathology to the functional status of geriatric psychiatric inpatients. General Hospital Psychiatry 20(3): 183-188, 1998

In geriatric patients, delirium symptoms are related to the anticholinergic burden. Geriatrics and Gerontology International 16(4): 424-431, 2017

Medical Burden, Cerebrovascular Disease, and Cognitive Impairment in Geriatric Depression: Modeling the Relationships With the Cart Analysis. Cns Spectrums 7(10): 716-722, 2002

Medical burden, cerebrovascular disease, and cognitive impairment in geriatric depression: modeling the relationships with the CART analysis. Cns Spectrums 7(10): 716-722, 2004

The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry 166(9): 1055-1062, 2009

Cognitive burden of anticholinergic medications in psychotic disorders. Schizophrenia Research 190: 129-135, 2017

Cognitive Burden of Anticholinergic Medications in Psychotic Disorders. Schizophrenia Bulletin 43(Suppl_1): S40-S41, 2017